Mitochondrial dysfunction associated with glucocerebrosidase deficiency
- PMID: 26388395
- PMCID: PMC4838669
- DOI: 10.1016/j.nbd.2015.09.006
Mitochondrial dysfunction associated with glucocerebrosidase deficiency
Abstract
The lysosomal hydrolase glucocerebrosidase (GCase) is encoded for by the GBA gene. Homozygous GBA mutations cause Gaucher disease (GD), a lysosomal storage disorder. Furthermore, homozygous and heterozygous GBA mutations are numerically the greatest genetic risk factor for developing Parkinson's disease (PD), the second most common neurodegenerative disorder. The loss of GCase activity results in impairment of the autophagy-lysosome pathway (ALP), which is required for the degradation of macromolecules and damaged organelles. Aberrant protein handling of α-synuclein by the ALP occurs in both GD and PD. α-synuclein is the principle component of Lewy bodies, a defining hallmark of PD. Mitochondrial dysfunction is also observed in both GD and PD. In this review we will describe how mitochondria are affected following loss of GCase activity. The pathogenic mechanisms leading to mitochondria dysfunction will also be discussed, focusing on the likely inhibition of the degradation of mitochondria by the ALP, also termed mitophagy. Other pathogenic cellular processes associated with GBA mutations that might contribute, such as the unfolding of GCase in the endoplasmic reticulum, calcium dysregulation and neuroinflammation will also be described. Impairment of the ALP and mitochondria dysfunction are common pathogenic themes between GD and PD and probably explain why GBA mutations increase the risk of developing PD that is very similar to sporadic forms of the disease.
Keywords: Autophagy; Gaucher disease; Glucocerebrosidase; Lysosome; Mitochondria; Parkinson's disease; mitophagy.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
The relationship between glucocerebrosidase mutations and Parkinson disease.J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):77-90. doi: 10.1111/jnc.13385. Epub 2016 Feb 10. J Neurochem. 2016. PMID: 26860875 Free PMC article. Review.
-
The role of glucocerebrosidase in Parkinson disease pathogenesis.FEBS J. 2018 Oct;285(19):3591-3603. doi: 10.1111/febs.14393. Epub 2018 Feb 19. FEBS J. 2018. PMID: 29385658 Review.
-
Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson's Disease: Pathogenesis and Therapeutic Implications.Front Aging Neurosci. 2022 Mar 23;14:851135. doi: 10.3389/fnagi.2022.851135. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35401150 Free PMC article. Review.
-
Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.Transl Neurodegener. 2021 Jan 15;10(1):4. doi: 10.1186/s40035-020-00226-x. Transl Neurodegener. 2021. PMID: 33446243 Free PMC article. Review.
-
Glucocerebrosidase and Parkinson disease: Recent advances.Mol Cell Neurosci. 2015 May;66(Pt A):37-42. doi: 10.1016/j.mcn.2015.03.013. Epub 2015 Mar 20. Mol Cell Neurosci. 2015. PMID: 25802027 Free PMC article. Review.
Cited by
-
Whole-exome sequencing reveals genetic variants that may play a role in neurocytomas.J Neurooncol. 2024 Feb;166(3):471-483. doi: 10.1007/s11060-024-04567-9. Epub 2024 Feb 6. J Neurooncol. 2024. PMID: 38319496
-
Meta-analysis of the association of prosaposin polymorphisms rs4747203 and rs885828 with risk of Parkinson's disease.Acta Neurol Belg. 2024 Jan 11. doi: 10.1007/s13760-023-02446-0. Online ahead of print. Acta Neurol Belg. 2024. PMID: 38206457
-
N-acetylcysteine Pharmacology and Applications in Rare Diseases-Repurposing an Old Antioxidant.Antioxidants (Basel). 2023 Jun 21;12(7):1316. doi: 10.3390/antiox12071316. Antioxidants (Basel). 2023. PMID: 37507857 Free PMC article. Review.
-
GBA1 Variants and Parkinson's Disease: Paving the Way for Targeted Therapy.J Mov Disord. 2023 Sep;16(3):261-278. doi: 10.14802/jmd.23023. Epub 2023 Jun 12. J Mov Disord. 2023. PMID: 37302978 Free PMC article.
-
The effects of bioactive components from the rhizome of gastrodia elata blume (Tianma) on the characteristics of Parkinson's disease.Front Pharmacol. 2022 Nov 30;13:963327. doi: 10.3389/fphar.2022.963327. eCollection 2022. Front Pharmacol. 2022. PMID: 36532787 Free PMC article. Review.
References
-
- Alcalay R.N., Caccappolo E., Mejia-Santana H., Tang M.-X., Rosado L., Orbe Reilly M., Ruiz D., Ross B., Verbitsky M., Kisselev S., Louis E., Comella C., Colcher A., Jennings D., Nance M., Bressman S., Scott W.K., Tanner C., Mickel S., Andrews H., Waters C., Fahn S., Cote L., Frucht S., Ford B., Rezak M., Novak K., Friedman J.H., Pfeiffer R., Marsh L., Hiner B., Siderowf A., Payami H., Molho E., Factor S., Ottman R., Clark L.N., Marder K. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology. 2012;78:1434–1440. - PMC - PubMed
-
- Alvarez-Erviti L., Rodriguez-Oroz M.C., Cooper J.M., Caballero C., Ferrer I., Obeso J.A., Schapira A.H.V. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch. Neurol. 2010;67:1464–1472. - PubMed
-
- Bembi B., Zambito Marsala S., Sidransky E., Ciana G., Carrozzi M., Zorzon M., Martini C., Gioulis M., Pittis M.G., Capus L. Gaucher's disease with Parkinson's disease: clinical and pathological aspects. Neurology. 2003;61:99–101. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
